Company Filing History:
Years Active: 2025
Title: James Stannard: Innovator in Neutron Capture Therapy
Introduction
James Stannard is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of medical technology, particularly in the area of infection control for surgical implants. His innovative approach combines the use of isotopes and low energy neutrons to enhance patient outcomes.
Latest Patents
Stannard holds a patent for "Neutron capture therapy for infection control of surgical implants." This invention provides an implant that comprises an isotope capable of producing a dose of ionizing radiation upon exposure to a flux of low energy neutrons. The method involves exposing the implant to low energy neutrons after implantation to control or treat infections. This groundbreaking work has the potential to improve the safety and effectiveness of surgical procedures.
Career Highlights
James Stannard is affiliated with the University of Missouri, where he continues to advance research in medical technology. His work has garnered attention for its innovative approach to addressing common complications associated with surgical implants. Stannard's dedication to improving patient care through technology is evident in his research and development efforts.
Collaborations
Stannard has collaborated with esteemed colleagues such as John Michel Gahl and John Brockman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.
Conclusion
James Stannard's contributions to neutron capture therapy represent a significant advancement in infection control for surgical implants. His work at the University of Missouri and his innovative patent highlight his commitment to improving healthcare outcomes. The impact of his research is poised to benefit many patients in the future.